Market Closed -
Japan Exchange
02:00:00 2024-05-29 am EDT
|
5-day change
|
1st Jan Change
|
1,000
JPY
|
+0.50%
|
|
-0.10%
|
+38.31%
|
Fiscal Period: June |
2023
|
---|
Capitalization
1 |
3,139
|
Enterprise Value (EV)
1 |
1,412
|
P/E ratio
|
8.7
x
|
Yield
|
3.25%
|
Capitalization / Revenue
|
0.98
x
|
EV / Revenue
|
0.44
x
|
EV / EBITDA
|
2,857,353
x
|
EV / FCF
|
7,969,131
x
|
FCF Yield
|
0%
|
Price to Book
|
1.27
x
|
Nbr of stocks (in thousands)
|
4,851
|
Reference price
2 |
647.0
|
Announcement Date
|
9/29/23
|
Fiscal Period: June |
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,062
|
3,115
|
3,190
|
EBITDA
|
-
|
-
|
494
|
EBIT
1 |
626
|
513
|
461
|
Operating Margin
|
20.44%
|
16.47%
|
14.45%
|
Earnings before Tax (EBT)
1 |
628
|
516
|
482
|
Net income
1 |
411
|
351
|
338
|
Net margin
|
13.42%
|
11.27%
|
10.6%
|
EPS
2 |
102.8
|
87.75
|
74.40
|
Free Cash Flow
|
-
|
-
|
177.1
|
FCF margin
|
-
|
-
|
5.55%
|
FCF Conversion (EBITDA)
|
-
|
-
|
35.86%
|
FCF Conversion (Net income)
|
-
|
-
|
52.4%
|
Dividend per Share
|
-
|
-
|
21.00
|
Announcement Date
|
11/18/22
|
11/18/22
|
9/29/23
|
Fiscal Period: June |
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
1,594
|
772
|
862
|
1,715
|
874
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
208
|
105
|
99
|
211
|
149
|
Operating Margin
|
13.05%
|
13.6%
|
11.48%
|
12.3%
|
17.05%
|
Earnings before Tax (EBT)
1 |
175
|
149
|
98
|
203
|
164
|
Net income
1 |
113
|
103
|
43
|
119
|
103
|
Net margin
|
7.09%
|
13.34%
|
4.99%
|
6.94%
|
11.78%
|
EPS
2 |
28.07
|
22.08
|
9.030
|
24.58
|
21.14
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/13/23
|
5/12/23
|
11/13/23
|
2/13/24
|
5/13/24
|
Fiscal Period: June |
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
Net Cash position
1 |
908
|
992
|
1,727
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
177
|
ROE (net income / shareholders' equity)
|
-
|
24.6%
|
16.8%
|
ROA (Net income/ Total Assets)
|
-
|
15.1%
|
11.5%
|
Assets
1 |
-
|
2,318
|
2,944
|
Book Value Per Share
2 |
326.0
|
388.0
|
508.0
|
Cash Flow per Share
2 |
302.0
|
323.0
|
356.0
|
Capex
|
-
|
-
|
73
|
Capex / Sales
|
-
|
-
|
2.29%
|
Announcement Date
|
11/18/22
|
11/18/22
|
9/29/23
|
|
1st Jan change
|
Capi.
|
---|
| +38.31% | 30.82M | | +4.99% | 18.87B | | +5.32% | 13.96B | | +10.00% | 10.36B | | -17.69% | 2.06B | | +3.83% | 1.76B | | +12.11% | 1.41B | | +8.14% | 573M | | 0.00% | 425M | | +76.68% | 204M |
Medical Prosthetics
|